Trends in good laboratory practice studies submitted for the marketing authorization of pharmaceuticals in Japan
Pharmaceuticals and Medical Devices Agencies (PMDA) receives the non-clinical safety studies following Good Laboratory Practice (GLP) for the marketing authorization of medical products. Here we analyzed the trends of GLP-compliant non-clinical studies (GLP studies) submitted to PMDA from FY2017 to...
Saved in:
| Main Authors: | Yusuke Oku, Hitoshi Someya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1591433/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Good Preclinical Study, as an Obligatory Stage in Design and Clinical Use of New Medicinal Preparations
by: A. N. Vasilyev
Published: (2020-05-01) -
Documentary support for preclinical studies <i>in vivo</i> in accordance with the principles of Good Laboratory Practice
by: S. V. Khodko, et al.
Published: (2025-07-01) -
EXPERIENCE OF CERTIFICATION BIOANALYTICAL LABORATORY ACCORDING TO REQUIREMENTS OF GOST 33044-2014 «PRINCIPLES OF GOOD LABORATORY PRACTICE» (GLP)
by: A. A. Krylatova, et al.
Published: (2019-01-01) -
Organisation of the Work of Bioanalytical Laboratories according to the Principles of Good Clinical Laboratory Practice (Review)
by: I. S. Giba
Published: (2024-11-01) -
The Integrated Model of Quality Management System of Laboratory Studies of Medicines (Review)
by: A. I. Selezneva, et al.
Published: (2021-08-01)